Fluke Biomedical Acquires Unfors RaySafe

Fluke Biomedical Acquires Unfors RaySafe
Fluke Biomedical, the world's leading manufacturer of biomedical test instruments, has announced the acquisition of Unfors RaySafe.

With this acquisition Fluke Biomedical adds industry leading quality assurance devices for diagnostic x-ray from Unfors RaySafe. With an enhanced portfolio especially in the fields of diagnostic x-ray, real-time dose monitoring systems for medical personnel and patient dose tracking software solutions, the Unfors RaySafe product line will broaden the Fluke Biomedical customer base and answer market demands with innovative and state-of-the-art solutions. Fluke Biomedical‘s goal is to provide healthcare providers, institutions and medical device manufacturers with a complete portfolio of test equipment.

Both companies see the user friendliness of their products, combined with advanced technology and maximum measurement accuracy as their major assets. "The fact that our companies share a similar culture is an ideal basis for continuing our excellent relationships with our employees, customers and partners," says Magnus Kristoferson, CEO of Unfors RaySafe. "We have experience in highly specialised markets all over the world, we know our business and we can now maximise our competencies. In the past, Unfors RaySafe has attracted the attention of the market not just for the functionality and measurement accuracy of its products, but also for the attractive design and intuitive user interface."

Fluke Biomedical leads the world in the manufacture of biomedical test and simulation products, including electrical safety testers, patient simulators, performance analysers, and fully-integrated and automated performance testing and documentation systems. Fluke Biomedical General Manager, Eric Conley says, "The acquisition of Unfors RaySafe brings to Fluke Biomedical a strong team that has delivered leading innovation to the radiation test and safety markets. The combination of Unfors RaySafe and Fluke Biomedical accelerates our ability to provide a broad portfolio of world class test equipment to our customers." With worldwide sales and distribution channels, Fluke Biomedical anticipates growth through innovative design and creative solutions for their customers. Fresh perspectives and product enhancements, coupled with the commitment to customer satisfaction, remain the hallmark of the organisation.

Source: RaySafe

6 February 2014

«« Three New Peer-Reviewed Publications Further Validate the Benefits of Hologic Tomosynthesis

Colon Camera Pill Receives US FDA Approval »»

Published on : Thu, 6 Feb 2014

Related Articles

Research supports the use of Hologic's lower dose 3D mammography technology and the continued use of two-views over one in breast... Read more

An innovative new technique developed by UNC researchers could enable doctors to visualise tumours without using radiation in... Read more

Dense breast tissue is a non-issue for molecular breast imaging According to the findings of a team of radiologists and... Read more

Imaging, X-ray, Dose, Technology, patient data, IT solutions, partnership, RaySafe, Fluke Biomedical Fluke Biomedical, the world's leading manufacturer of biomedical test instruments, has announced the acquisition of Unfors RaySafe. With this acquisitio...

No comment

Please login to leave a comment...

Highlighted Products